Market Overview

Pituitary ACTH Hypersecretion (Cushing's Disease) - Pipeline Insight, 2018 - ResearchAndMarkets.com

Share:

The "Pituitary
ACTH Hypersecretion (Cushing's Disease) - Pipeline Insight, 2018"

drug pipelines has been added to ResearchAndMarkets.com's
offering.

This report offers a comprehensive insight of the pipeline (under
development) therapeutics scenario and growth prospects across Pituitary
ACTH Hypersecretion (Cushing's Disease) development.

The report provides detailed coverage of the pipeline landscape for this
mechanism of action, equipped with data from multiple sources with
complete pipeline analysis by developmental stage, associated
indications, route of administration and molecule type.

Scope

  • The report provides a snapshot of the pipeline development for
    Pituitary ACTH Hypersecretion (Cushing's Disease)
  • The report covers pipeline activity across the complete product
    development cycle i.e. clinical, pre-clinical and discovery stages for
    Pituitary ACTH Hypersecretion (Cushing's Disease)
  • The report provides pipeline product profiles which includes product
    description, developmental activities, licensors & collaborators and
    chemical information
  • Provides pipeline assessment by monotherapy and combination therapy
    products, stage of development, route of administration, and molecule
    type for Pituitary ACTH Hypersecretion (Cushing's Disease)
  • The report also covers the dormant and discontinued pipeline projects
    related to Pituitary ACTH Hypersecretion (Cushing's Disease)

Companies Featured

  • Amryt Pharma PLC
  • Crinetics Pharmaceuticals, Inc.
  • Cyclacel Pharmaceuticals, Inc.
  • Millendo Therapeutics, Inc.
  • Novartis AG
  • Pfizer Inc.
  • Strongbridge Biopharma PLC

Key Topics Covered

1. Report Introduction

2. Pituitary ACTH Hypersecretion (Cushing's Disease) Overview

3. Pipeline Therapeutics

  • An Overview of Pipeline Products for Pituitary ACTH Hypersecretion
    (Cushing's Disease)

4. Comparative Analysis

5. Products in Clinical Stage

5.1 Drug Name: Company Name

  • Product Description
  • Research and Development
  • Product Development Activities

6. Products in Pre-Clinical and Discovery Stage

6.1 Drug Name: Company Name

  • Product Description
  • Research and Development
  • Product Development Activities

7. Therapeutic Assessment

  • Assessment by Route of Administration
  • Assessment by Stage and Route of Administration
  • Assessment by Molecule Type
  • Assessment by Stage and Molecule Type

8. Inactive Products

8.1 Drug Name: Company Name

  • Product Description
  • Research and Development
  • Product Development Activities

For more information about this drug pipelines report visit https://www.researchandmarkets.com/research/m49f9x/pituitary_acth?w=4.

View Comments and Join the Discussion!